The genes in IL-6 high-expression group were mainly enriched in immune-related activities, such as inflammatory response and IL-6-JAK-STAT3 signaling pathway, and typical tumor pathways, such as KRAS, P53, and TGF-β pathway (Figure 4(b)). This evidence concerns the gene KRAS and neoplasm.